✦ LIBER ✦

Augmentation of the lymphokine-activated killer cell response in head and neck cancer patients by combination interleukin-2 and interferon-alpha

✍ Scribed by Harold Wanebo; Dilshad Blackinton; Tracey Weigel; Peter Turk; Shashi Mehta

Book ID: 115695251
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 483 KB
Volume: 162
Category: Article
ISSN: 0002-9610
DOI: 10.1016/0002-9610(91)90154-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of lymphokine-activated kille

Inhibition of lymphokine-activated killer cell generation by blocking factors in sera of patients with head and neck cancer

✍ Samuel P. Bugis; Eva Lotzová; Howard E. Savage; Jeane P. Hester; Tamas Racz; Pet 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 897 KB

Cytotoxicity of interleukin 2-induced ly

Cytotoxicity of interleukin 2-induced lymphokine-activated killer (LAK) cells against human leukemia and augmentation of killing by interferons and tumor necrosis factor

✍ Johannes V. Teichmann; Wolf-Dieter Ludwig; Eckhard Thiel 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 986 KB

Levels of soluble interleukin-2 receptor

Levels of soluble interleukin-2 receptors are predictive of response in patients treated with interleukin-2 and lymphokine-activated killer cells

✍ Elisabeth Paietta; David L. Nelson; Janet Andersen; Janice P. Dutcher; Peter H. 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 428 KB

Interferon-γ (IFN-γ) and interleukin-2 i

Interferon-γ (IFN-γ) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity — IFN-γ-induced suppressive activity

✍ Michel Toledano; Claire Mathiot; Jean Michon; Georges Andreu; Danielle Lando; Ma 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 1006 KB

The systemic complement activation cause

The systemic complement activation caused by interleukin-2/lymphokine-activated killer-cell therapy of cancer causes minimal systemic neutrophil activation

✍ Francis D. Moore Jr; Deric D. Schoof; Mary Rodrick; Timothy J. Eberlein 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 617 KB

Twenty-three cancer patients undergoing therapy with interleukin-2 and lymphokine-activated killer cells were studied for evidence of complement activation and systemic neutrophil activation occurring during the course of therapy. Patient plasma samples demonstrated evidence of marked complement act

Recombinant interleukin-2 and lymphokine

Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. phenotypic and functional analysis of the peripheral blood mononuclear cells

✍ Claudio Fortis; Elisabetta Ferrero; Carlo Besana; Mauro Biffi; Silvia Heltai; La 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 735 KB